Evidence map›Paper›PMID 29523778›Full record

ArticleNature communications2018

Publisher Correction: Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets.

Zachary R Crook, Gregory P Sevilla, Della Friend, Mi-Youn Brusniak, Ashok D Bandaranayake, Midori Clarke, Mesfin Gewe, Andrew J Mhyre, David Baker, Roland K Strong and 2 more

Abstract readPublished Erratum
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Zachary R CrookClinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N Room D4-100, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0002-1142-9748
Gregory P SevillaClinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N Room D4-100, Seattle, WA, 98109, USA.
Della FriendBasic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N Room B3-183, Seattle, WA, 98109, USA.
Mi-Youn BrusniakClinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N Room D4-100, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0003-3950-1614
Ashok D BandaranayakeClinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N Room D4-100, Seattle, WA, 98109, USA.
Midori ClarkeClinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N Room D4-100, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0002-2402-108X
Mesfin GeweBasic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N Room B3-183, Seattle, WA, 98109, USA.
Andrew J MhyreClinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N Room D4-100, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0002-9206-3150
David BakerDepartment of Biochemistry, University of Washington, Molecular Engineering and Sciences, Box 351655, Seattle, WA, 98109, USA.
Roland K StrongBasic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N Room B3-183, Seattle, WA, 98109, USA.
Philip BradleyPublic Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N Room M1-B514, Seattle, WA, 98109, USA. pbradley@fredhutch.org.
James M OlsonClinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N Room D4-100, Seattle, WA, 98109, USA. jimmyo@uw.edu.

Funding

Testing a cancer patient-specific SARS-CoV-2 vaccine in chemotherapy- and radiation-treated pediatric brain tumor mouse modelsR01CA114567 · NCI · SEATTLE CHILDREN'S HOSPITAL · PI OLSON, JAMES M · 2006 to 2023
$4.9M
Chlorotoxin as a Targeting Agent for Cancer TherapiesR01CA135491 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OLSON, JAMES M · 2008 to 2018
$3.8M
Engineering Knotted Peptide Therapeutics for Pediatric Brain Tumor PatientsR01CA223674 · NCI · SEATTLE CHILDREN'S HOSPITAL · PI OLSON, JAMES M · 2018 to 2022
$3.6M
Infant and Toddler Brain TumorsR01CA155360 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OLSON, JAMES M · 2011 to 2015
$1.8M
NCI NIH HHS R01 CA135491NCI NIH HHS R01 CA155360NCI NIH HHS R01 CA223674
6 · The paper itself

Abstract

In the original version of this Article the colour key for the amino acid enrichment score was inadvertently omitted from the lower panel of Figure 5b during the production process. This has now been corrected in the PDF and HTML versions of the Article.

Identifiers

PMID29523778
PMCPMC5844863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.